Ocular Hypertension Completed Phase 3 Trials for Travoprost (DB00287)

Also known as: Hypertension Ocular / Intraocular pressure high / Intraocular hypertension / Intraocular pressure raised / Ocular Hypertension (OHT) / Ocular Hypertension (OH) / Hypertension, Ocular / Elevated Intraocular Pressure / Intraocular pressure increased / IOP increased / Raised IOP / Ocular tension increased / Tension ocular increased / Pressure intraocular increased / Increased intraocular pressure

IndicationStatusPhase
DBCOND0074237 (Ocular Hypertension)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02914509OTX-16-002: A Phase 3 Study Evaluating the Safety and Efficacy of OTX-TP in Subjects With Open-Angle Glaucoma and Ocular HypertensionTreatment
NCT00892762Travoprost APS Versus Xalatan® in Patient Reported Outcomes and Ocular Surface HealthTreatment
NCT00928590Safety Study of DuoTrav APS in Patients With Open-Angle Glaucoma or Ocular HypertensionTreatment
NCT00872651Travoprost 0.004%/Timolol 0.5% Versus Latanoprost 0.005%/Timolol in Chinese Patients With Open-Angle Glaucoma or Ocular HypertensionTreatment
NCT00848536Efficacy Study of Travoprost APS Versus TRAVATANTreatment
NCT00761319Phase III Clinical Trial of TRAVATAN Z in Ocular Surface HealthTreatment
NCT00760539Safety and Efficacy of Travoprost/Timolol BAC-freeTreatment
NCT00051155A 6-Week Safety and Efficacy Study of Travatan Compared to Xalcom in Subjects With Open-Angle Glaucoma(OAG) or Ocular Hypertension(OHT)Treatment
NCT01453855Travoprost 3-Month Safety and Efficacy StudyTreatment
NCT00051181A Safety and Efficacy Study of Travoprost 0.004% Compared to Latanoprost 0.005% in Patients With Chronic Angle-Closure GlaucomaTreatment
NCT00051142A Safety and Efficacy Study of Travoprost 0.004% Compared to Latanoprost 0.005% in Patients With Open-Angle Glaucoma (OAG) or Ocular Hypertension (OHT)Treatment
NCT00051168A Long-term Safety Study of Once-daily TravatanTreatment
NCT00672997A Phase III Study of Travoprost/Timolol Combination in Patients With Open-Angle Glaucoma or Ocular HypertensionTreatment
NCT00690794Travatan Z in Ocular Surface Health in Patients With Open-Angle Glaucoma or Ocular HypertensionTreatment
NCT00465803A Phase IIIb Study of DuoTrav to Treat Glaucoma or Ocular HypertensionTreatment
NCT00311389A 12-Month Study to Evaluate the Efficacy and Safety of Once-Daily Instillation of Combination Glaucoma Therapy in Patients With Open-Angle Glaucoma or Ocular HypertensionTreatment
NCT00293787A Study of Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular HypertensionTreatment
NCT00293800A Study of Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular HypertensionTreatment
NCT00293761A Study of Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular HypertensionTreatment
NCT00333125A Study of Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular HypertensionTreatment